Tri Locum Partners LP 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Tri Locum Partners LP disclosed 19 US equity positions worth $813.2m in its Q2 2026 13F filing. The largest position was JNJ at 13.3% of the reported book, followed by VRTX and LLY. Against the Q1 2026 filing, it opened 5 new positions, added to 8 and reduced 6 among the top 19 holdings.
What did Tri Locum Partners LP own in Q2 2026? Top 19 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | JNJ JOHNSON & JOHNSON | Healthcare | 13.3% | $107.9m | 424,945 | 3% | added |
| 2 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 12.3% | $100.2m | 201,791 | 56% | added |
| 3 | LLY ELI LILLY & CO | Healthcare | 11.3% | $91.8m | 76,532 | 24% | added |
| 4 | ASND ASCENDIS PHARMA A/S | Healthcare | 8.5% | $69.0m | 258,740 | – | new |
| 5 | DXCM DEXCOM INC | Healthcare | 6.8% | $55.3m | 820,479 | 18% | added |
| 6 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 6.6% | $53.7m | 219,308 | 253% | added |
| 7 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 6.6% | $53.4m | 221,720 | 40% | added |
| 8 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 5.4% | $44.0m | 866,716 | – | new |
| 9 | ARGX ARGENX SE | Healthcare | 4.7% | $38.6m | 41,596 | 31% | added |
| 10 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 4.5% | $36.7m | 68,273 | -34% | reduced |
| 11 | RVMD REVOLUTION MEDICINES INC | Healthcare | 3.5% | $28.4m | 151,822 | – | new |
| 12 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.1% | $25.5m | 47,026 | -33% | reduced |
| 13 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 3.1% | $25.3m | 746,835 | -27% | reduced |
| 14 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 2.5% | $20.7m | 328,340 | 30% | added |
| 15 | ISRG INTUITIVE SURGICAL INC | Healthcare | 2.3% | $19.1m | 47,983 | -69% | reduced |
| 16 | CYTK CYTOKINETICS INC | Healthcare | 2.0% | $16.5m | 194,000 | – | new |
| 17 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.4% | $11.8m | 120,712 | -17% | reduced |
| 18 | BBNX BETA BIONICS INC | Healthcare | 1.0% | $7.7m | 493,344 | – | new |
| 19 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 0.9% | $7.7m | 162,996 | -56% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.